LabCorp Venture Fund logo

LabCorp Venture Fund

North America, North Carolina, United States, Burlington

Description

LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces.

Investor Profile

LabCorp Venture Fund has made 12 investments, with 3 in the past 12 months and 25% as lead.

Stage Focus

  • Series Unknown (42%)
  • Series B (17%)
  • Series A (17%)
  • Series E (8%)
  • Convertible Note (8%)
  • Seed (8%)

Country Focus

  • United States (83%)
  • Switzerland (8%)
  • Denmark (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Medical
  • Clinical Trials
  • Product Research
  • Medical Device
  • Wearables
  • Veterinary
  • Women's
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LabCorp Venture Fund frequently co-invest with?

Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
MF
North America, North Carolina, United States, Wallace
Co-Investments: 1
Breakout Ventures
North America, California, United States, San Francisco
Co-Investments: 2
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
BA
North America, New York, United States, Buffalo
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
RH Capital
North America, California, United States, San Francisco
Co-Investments: 2
Rochester Angel Network
North America, New York, United States, West Henrietta
Co-Investments: 2
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 1
Western New York Impact Investment Fund
North America, New York, United States, Buffalo
Co-Investments: 2

What are some of recent deals done by LabCorp Venture Fund?

Praia Health

Chicago, Illinois, United States

Praia Health is a modern consumer platform for health systems that transforms the delivery of tailored health solutions on a large scale.

Health CareHospitalMedicalWellness
Series UnknownNov 4, 2024
GLX Analytix

Copenhagen, Hovedstaden, Denmark

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.

BiotechnologyHealth CareMedicalPrecision Medicine
Series UnknownOct 29, 2024
NOWDiagnostics

Springdale, Arkansas, United States

NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.

Health DiagnosticsManufacturingMedical Device
Series BJul 9, 2024
Amount Raised: $22,500,000
Prolocor

Philadelphia, Pennsylvania, United States

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

BiotechnologyHealth CareHealth DiagnosticsMedical
Convertible NoteFeb 27, 2024
Amount Raised: $1,700,000
AOA

Boulder, Colorado, United States

AOA Dx is a biotech company developing cancer diagnostics in the field of women’s health.

BiotechnologyHealth CareHealth Diagnostics
Series AOct 11, 2023
Amount Raised: $17,000,000
Evvy

New York, New York, United States

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

BiotechnologyHealth CareWomen's
Series ASep 27, 2023
Amount Raised: $14,000,000
Circuit Clinical

Buffalo, New York, United States

Circuit Clinical is an integrated research organization providing turnkey end-to-end solutions for clinical trials.

Clinical TrialsHealth CareProduct Research
Series UnknownMar 10, 2022
Amount Raised: $29,000,000
Biospectal

Lausanne, Vaud, Switzerland

Biospectal mission to reinvent medical sensing and monitoring through ubiquitous connected devices, IoT, and edge computing technologies.

Health CareHealth DiagnosticsMedicalMedical DeviceSoftwareWearables
SeedJul 1, 2021
Amount Raised: $4,319,878
Advanced Animal Diagnostics

Morrisville, North Carolina, United States

Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.

BiotechnologyHealth DiagnosticsVeterinary
Series EMay 11, 2021
Amount Raised: $7,000,000
Presage Biosciences

Seattle, Washington, United States

Presage Biosciences develops a technology platform to improve the cancer drug development process.

BiotechnologyHealth CareMedical
Series UnknownMar 2, 2021
Amount Raised: $7,000,000